BERRINO, LIBERATO
BERRINO, LIBERATO
Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors
2023-01-01 Donniacuo, M; De Angelis, A; Telesca, M; Bellocchio, G; Riemma, M A; Paolisso, P; Scisciola, L; Cianflone, E; Torella, D; Castaldo, G; Capuano, A; Urbanek, K; Berrino, L; Rossi, F; Cappetta, D
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
2018-01-01 Gorini, Stefania; De Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta
Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib"
2019-01-01 Gorini, Stefania; De Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta
Corrigendum to Chemotherapeutic drugs and mitochondrial dysfunction: focus on Doxorubicin , Trastuzumab and Sunitinib
2019-01-01 Gorini, Stefania; antonella de angelis, ; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta
COVID-19 and atrial fibrillation: Intercepting lines
2023-01-01 Donniacuo, Maria; De Angelis, Antonella; Rafaniello, Concetta; Cianflone, Eleonora; Paolisso, Pasquale; Torella, Daniele; Sibilio, Gerolamo; Paolisso, Giuseppe; Castaldo, Giuseppe; Urbanek, Konrad; Rossi, Francesco; Berrino, Liberato; Cappetta, Donato
Current and future therapeutic perspective in chronic heart failure
2022-01-01 Mascolo, A.; di Mauro, G.; Cappetta, D.; De Angelis, A.; Torella, D.; Urbanek, K.; Berrino, L.; Nicoletti, G. F.; Capuano, A.; Rossi, F.
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome
2023-01-01 Urbanek, Konrad; Cappetta, Donato; Bellocchio, Gabriella; Coppola, Maria Antonietta; Imbrici, Paola; Telesca, Marialucia; Donniacuo, Maria; Riemma, Maria Antonietta; Mele, Elena; Cianflone, Eleonora; Naviglio, Silvio; Conte, Elena; Camerino, Giulia Maria; Mele, Marco; Bucci, Mariarosaria; Castaldo, Giuseppe; De Luca, Annamaria; Rossi, Francesco; Berrino, Liberato; Liantonio, Antonella; De Angelis, Antonella
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch
2024-01-01 Telesca, M.; Donniacuo, M.; Bellocchio, G.; Riemma, M. A.; Mele, E.; Dell'Aversana, C.; Sgueglia, G.; Cianflone, E.; Cappetta, D.; Torella, D.; Altucci, L.; Castaldo, G.; Rossi, F.; Berrino, L.; Urbanek, K.; De Angelis, A.
Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey
2021-01-01 Cappetta, D.; De Angelis, A.; Bellocchio, G.; Telesca, M.; Cianflone, E.; Torella, D.; Rossi, F.; Urbanek, K.; Berrino, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors | 1-gen-2023 | Donniacuo, M; De Angelis, A; Telesca, M; Bellocchio, G; Riemma, M A; Paolisso, P; Scisciola, L; Cianflone, E; Torella, D; Castaldo, G; Capuano, A; Urbanek, K; Berrino, L; Rossi, F; Cappetta, D | |
| Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib | 1-gen-2018 | Gorini, Stefania; De Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta | |
| Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib" | 1-gen-2019 | Gorini, Stefania; De Angelis, Antonella; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta | |
| Corrigendum to Chemotherapeutic drugs and mitochondrial dysfunction: focus on Doxorubicin , Trastuzumab and Sunitinib | 1-gen-2019 | Gorini, Stefania; antonella de angelis, ; Berrino, Liberato; Malara, Natalia; Rosano, Giuseppe; Ferraro, Elisabetta | |
| COVID-19 and atrial fibrillation: Intercepting lines | 1-gen-2023 | Donniacuo, Maria; De Angelis, Antonella; Rafaniello, Concetta; Cianflone, Eleonora; Paolisso, Pasquale; Torella, Daniele; Sibilio, Gerolamo; Paolisso, Giuseppe; Castaldo, Giuseppe; Urbanek, Konrad; Rossi, Francesco; Berrino, Liberato; Cappetta, Donato | |
| Current and future therapeutic perspective in chronic heart failure | 1-gen-2022 | Mascolo, A.; di Mauro, G.; Cappetta, D.; De Angelis, A.; Torella, D.; Urbanek, K.; Berrino, L.; Nicoletti, G. F.; Capuano, A.; Rossi, F. | |
| Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome | 1-gen-2023 | Urbanek, Konrad; Cappetta, Donato; Bellocchio, Gabriella; Coppola, Maria Antonietta; Imbrici, Paola; Telesca, Marialucia; Donniacuo, Maria; Riemma, Maria Antonietta; Mele, Elena; Cianflone, Eleonora; Naviglio, Silvio; Conte, Elena; Camerino, Giulia Maria; Mele, Marco; Bucci, Mariarosaria; Castaldo, Giuseppe; De Luca, Annamaria; Rossi, Francesco; Berrino, Liberato; Liantonio, Antonella; De Angelis, Antonella | |
| Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch | 1-gen-2024 | Telesca, M.; Donniacuo, M.; Bellocchio, G.; Riemma, M. A.; Mele, E.; Dell'Aversana, C.; Sgueglia, G.; Cianflone, E.; Cappetta, D.; Torella, D.; Altucci, L.; Castaldo, G.; Rossi, F.; Berrino, L.; Urbanek, K.; De Angelis, A. | |
| Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey | 1-gen-2021 | Cappetta, D.; De Angelis, A.; Bellocchio, G.; Telesca, M.; Cianflone, E.; Torella, D.; Rossi, F.; Urbanek, K.; Berrino, L. |